Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	7.08T
Revenue (ttm)	2.16T
Net Income (ttm)	72.94B
Shares Out	82.34M
EPS (ttm)	885.79
PE Ratio	97.09
Forward PE	n/a
Dividend	1,000.00 (1.16%)
Ex-Dividend Date	Oct 30, 2024

Volume	3,526
Average Volume	15,565
Open	87,100
Previous Close	86,500
Day's Range	85,300 - 87,100
52-Week Range	67,500 - 110,900
Beta	0.22
RSI	51.17
Earnings Date	Aug 7, 2025

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.